On Monday, ProKidney Corp (NASDAQ: PROK) opened lower -5.88% from the last session, before settling in for the closing price of $2.21. Price fluctuations for PROK have ranged from $0.46 to $7.13 over the past 52 weeks.
Company’s average yearly earnings per share was noted 7.61% at the time writing. With a float of $105.52 million, this company’s outstanding shares have now reached $135.98 million.
ProKidney Corp (PROK) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ProKidney Corp is 25.45%, while institutional ownership is 28.52%. The most recent insider transaction that took place on Nov 13 ’25, was worth 1,190,062. In this transaction Director of this company sold 502,136 shares at a rate of $2.37, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Director sold 255,026 for $2.72, making the entire transaction worth $694,515. This insider now owns 54,333 shares in total.
ProKidney Corp (PROK) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.17 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.15) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.61% per share during the next fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
Check out the current performance indicators for ProKidney Corp (PROK). In the past quarter, the stock posted a quick ratio of 10.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 845.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
The latest stats from [ProKidney Corp, PROK] show that its last 5-days average volume of 1.06 million was inferior to 4.4 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 16.01%.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 2.65%, which indicates a significant decrease from 6.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.17 in the past 14 days, which was lower than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.68, while its 200-day Moving Average is $1.91. Now, the first resistance to watch is $2.17. This is followed by the second major resistance level at $2.27. The third major resistance level sits at $2.32. If the price goes on to break the first support level at $2.02, it is likely to go to the next support level at $1.97. The third support level lies at $1.87 if the price breaches the second support level.
ProKidney Corp (NASDAQ: PROK) Key Stats
There are currently 300,834K shares outstanding in the company with a market cap of 625.73 million. Presently, the company’s annual sales total 80 K according to its annual income of -61,190 K. Last quarter, the company’s sales amounted to 220 K and its income totaled -16,470 K.
